Hereditary Cancer
Identify how your patient’s genetics may facilitate preventative interventions and early detection, as well as recognize at-risk family members.
Sequence Once, Query Often®
Existing Patient (SOQO)®
≤ 5 days
New Patient
6-21 days
Sample
Saliva, Blood, Buccal
One comprehensive test provides clinical answers today and enables future queries as science evolves. If your patient has been sequenced before, Helix will automatically flag them as an existing patient in your EHR ordering workflow. No new sample required.
Test Catalog
Select a test below to view a detailed test description, technical specifications and complete gene list.
Clinical Utility
Identifies individuals with a hereditary predisposition to cancer who may benefit from:
- Increased cancer screening
- Risk-reducing surgeries
- Chemoprevention
- Targeted therapies (e.g., PARP inhibitors)
- Clarification of risk for family members
Tech Specs
Methodology
Exome+® NGS (exome capture + deep intronic coverage in key regions + relevant promoters and inversions).
Accuracy
> 99.9% analytical sensitivity for SNVs and small indels.
CNV Resolution
Single exon-level resolution for deletions and duplications.
Wayfinder™ Interpretation
Automated pathogenicity scoring powered by 3M+ longitudinal records and AI synthesis for superior intelligence.
Ready to get started?
Connect with our team to learn how Helix can transform your practice with comprehensive genomic testing.